Difference between revisions of "Matsuyama S, et al, J Virol (2010), cited as Ref 11 in DOI: 10.1007/s11886-020-01293-2 (Q11005)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): Nagata N, #quickstatements; #temporary_batch_1592835517245) |
(Created claim: Third Author string (P151): Shirato K, #quickstatements; #temporary_batch_1592835612481) |
||
| Property / Third Author string | |||
| + | Shirato K | ||
| Property / Third Author string: Shirato K / rank | |||
| + | Normal rank | ||
Revision as of 14:20, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Matsuyama S, et al, J Virol (2010), cited as Ref 11 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 (English)
0 references
2010
0 references
Matsuyama S
0 references
Nagata N
0 references
Shirato K
0 references
